FDA 483 - Quagen Pharma, LLC - October 26, 2020

An FDA inspection of Quagen Pharma, LLC, a drug manufacturer in West Caldwell, NJ, identified two significant observations. These observations highlight failures in personnel gowning practices, leading to potential drug product contamination, and a lack of adherence to written procedures for preparing sanitizing solutions used in equipment maintenance.